{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:57:22Z","timestamp":1783130242749,"version":"3.54.6"},"reference-count":109,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>The literature has long established the association between aging and frailty, with emerging evidence pointing to a relationship between frailty and SARS-CoV-2 contagion. The possible neurological consequences of SARS-CoV-2 infection, associated with physical and cognitive frailty, could lead to a worsening of Parkinson\u2019s disease (PD) in infected patients or\u2014more rarely\u2014to an increase in the Parkinsonian symptomatology. A possible link between those clinical pictures could be identified in vitamin D deficiency, while the whole process would appear to be associated with alterations in the microbiota\u2013intestine\u2013brain axis that fall within the \u03b1-Synuclein Origin site and Connectome (SOC) model, and allow for the identification of a body-first PD and a brain-first PD. The model of care for this condition must consider intrinsic and extrinsic variables so that care by a multidisciplinary team can be successfully predicted. A multidimensional screening protocol specifically designed to identify people at risk or in the early stages of the disease should begin with the investigation of indices of frailty and microbiota\u2013intestine\u2013brain axis alterations, with a new focus on cases of hypovitaminosis D.<\/jats:p>","DOI":"10.3390\/brainsci13040528","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T04:37:28Z","timestamp":1679546248000},"page":"528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Parkinson\u2019s Disease, SARS-CoV-2, and Frailty: Is There a Vicious Cycle Related to Hypovitaminosis D?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-3793","authenticated-orcid":false,"given":"Sara","family":"Palermo","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Turin, 10124 Turin, Italy"},{"name":"Neuroradiology Unit, Diagnostic and Technology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-0965","authenticated-orcid":false,"given":"Mario","family":"Stanziano","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Diagnostic and Technology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, 20133 Milan, Italy"},{"name":"Neurosciences Department \u201cRita Levi Montalcini\u201d, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-5458","authenticated-orcid":false,"given":"Anna","family":"Nigri","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Diagnostic and Technology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-8032","authenticated-orcid":false,"given":"Cristina","family":"Civilotti","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Turin, 10124 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-3564","authenticated-orcid":false,"given":"Alessia","family":"Celeghin","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Turin, 10124 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"ref_1","unstructured":"Baddour, M.M. (2021). Fighting the COVID-19 Pandemic, IntechOpen Limited."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"558835","DOI":"10.3389\/fmed.2020.558835","article-title":"COVID-19 Pandemic: Maximizing Future Vaccination Treatments Considering Aging and Frailty","volume":"7","author":"Palermo","year":"2020","journal-title":"Front. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10072-020-04450-1","article-title":"An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)","volume":"41","author":"Ferrarese","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_5","first-page":"1343","article-title":"Parkinsonism as a Third Wave of the COVID-19 Pandemic?","volume":"10","author":"Beauchamp","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_6","first-page":"431","article-title":"Parkinson\u2019s Disease and the COVID-19 Pandemic","volume":"11","author":"Fearon","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fmed.2017.00199","article-title":"Neuropsychological Correlates of Pre-Frailty in Neurocognitive Disorders: A Possible Role for Metacognitive Dysfunction and Mood Changes","volume":"4","author":"Amanzio","year":"2017","journal-title":"Front. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"554307","DOI":"10.3389\/fpsyg.2020.554307","article-title":"A Possible Association Between Executive Dysfunction and Frailty in Patients with Neurocognitive Disorders","volume":"11","author":"Bartoli","year":"2020","journal-title":"Front. Psychol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11912-021-01097-9","article-title":"Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers","volume":"23","author":"Diebel","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_10","first-page":"100116","article-title":"SARS-CoV-2 induced Parkinsonism: The first case from the sub-Saharan Africa","volume":"5","author":"Ayele","year":"2021","journal-title":"Clin. Park. Relat. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mds.28656","article-title":"Parkinsonism as a Sequela of SARS-CoV-2 Infection: Pure Hypoxic Injury or Additional COVID-19-Related Response?","volume":"36","author":"Fearon","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cbf.3597","article-title":"Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?","volume":"39","author":"Ferrari","year":"2021","journal-title":"Cell. Biochem. Funct."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"D\u2019Amelio, P., and Quacquarelli, L. (2020). Hypovitaminosis D and Aging: Is There a Role in Muscle and Brain Health?. Nutrients, 12.","DOI":"10.3390\/nu12030628"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Barichella, M., Garr\u00ec, F., Caronni, S., Bolliri, C., Zocchi, L., Macchione, M.C., Ferri, V., Calandrella, D., and Pezzoli, G. (2022). Vitamin D Status and Parkinson\u2019s Disease. Brain Sci., 12.","DOI":"10.3390\/brainsci12060790"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molmed.2022.06.005","article-title":"Olfactory dysfunction in COVID-19: Pathology and long-term implications for brain health","volume":"28","author":"Doty","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2020.06.032","article-title":"COVID-19 and the Chemical Senses: Supporting Players Take Center Stage","volume":"107","author":"Cooper","year":"2020","journal-title":"Neuron"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Karlafti, E., Georgakopoulou, V.E., Papalexis, P., Papageorgiou, S.G., Tegos, T., and Savopoulos, C. (2023). Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson\u2019s Disease. Life, 13.","DOI":"10.3390\/life13020536"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","article-title":"Prevalence of smell loss in Parkinson\u2019s disease\u2014A multicenter study","volume":"15","author":"Haehner","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2020.09.008","article-title":"COVID-19 in Parkinson\u2019s disease: Report on prevalence and outcome","volume":"80","author":"Artusi","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10072-021-05756-4","article-title":"Parkinson\u2019s disease and COVID-19: A systematic review and meta-analysis","volume":"43","author":"Khoshnood","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28104","article-title":"Outcome of Parkinson\u2019s Disease Patients Affected by COVID-19","volume":"35","author":"Antonini","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"590134","DOI":"10.3389\/fpsyt.2020.590134","article-title":"Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson\u2019s Disease and Mild Cognitive Impairment During the COVID-19 Lockdown","volume":"11","author":"Baschi","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/mds.28170","article-title":"Effects of COVID-19 on Parkinson\u2019s Disease Clinical Features: A Community-Based Case-Control Study","volume":"35","author":"Cilia","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.irn.2022.04.004","article-title":"COVID-19 and Parkinson\u2019s disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism","volume":"165","author":"Leta","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cortex.2021.05.003","article-title":"A subcortical network for implicit visuo-spatial attention: Implications for Parkinson\u2019s Disease","volume":"141","author":"Esposito","year":"2021","journal-title":"Cortex"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.jchemneu.2021.101965","article-title":"COVID-19 and Parkinson\u2019s disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia","volume":"115","author":"Rethinavel","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sadasivan, S., Zanin, M., O\u2019Brien, K., Schultz-Cherry, S., and Smeyne, R.J. (2015). Induction of microglia activation after infection with the non-neurotropic A\/CA\/04\/2009 H1N1 influenza virus. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124047"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mysiris, D.S., Vavougios, G.D., Karamichali, E., Papoutsopoulou, S., Stavrou, V.T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., and Zarogiannis, S.G. (2022). Post-COVID-19 Parkinsonism and Parkinson\u2019s Disease Pathogenesis: The Exosomal Cargo Hypothesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179739"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson\u2019s disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","article-title":"Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease--is there a link?","volume":"47","author":"Tyson","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s Disease: Biomarkers, Treatment, and Risk Factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Kuhn","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mds.870070210","article-title":"Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson\u2019s disease","volume":"7","author":"Fazzini","year":"1992","journal-title":"Mov. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1212\/WNL.0000000000010282","article-title":"Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection","volume":"95","year":"2020","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","article-title":"A case of probable Parkinson\u2019s disease after SARS-CoV-2 infection","volume":"19","author":"Cohen","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/mds.28277","article-title":"Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case","volume":"35","author":"Faber","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1007\/s00415-021-10560-3","article-title":"SARS-CoV-2-related encephalitis with prominent parkinsonism: Clinical and FDG-PET correlates in two patients","volume":"268","author":"Morassi","year":"2021","journal-title":"J. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MCO.0b013e32835ada13","article-title":"Inflamm-aging","volume":"16","author":"Cevenini","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hussien, H., Nastasa, A., Apetrii, M., Nistor, I., Petrovic, M., and Covic, A. (2021). Different aspects of frailty and COVID-19: Points to consider in the current pandemic and future ones. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02316-5"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/gerona\/glx042","article-title":"Biological Aging and the Human Gut Microbiota","volume":"72","author":"Maffei","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(09)60658-9","article-title":"Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial","volume":"373","author":"Schweickert","year":"2009","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10522-010-9292-5","article-title":"Frailty, inflammation and the elderly","volume":"11","author":"Hubbard","year":"2010","journal-title":"Biogerontology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.18632\/aging.102988","article-title":"Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections","volume":"12","author":"Zhavoronkov","year":"2020","journal-title":"Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1177\/0300060518762040","article-title":"Long-term sequelae of acute respiratory distress syndrome caused by severe community-acquired pneumonia: Delirium-associated cognitive impairment and post-traumatic stress disorder","volume":"46","author":"Denke","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/CCM.0000000000000205","article-title":"Systemic infections may cause cognitive deterioration and neurodegeneration","volume":"42","author":"Chiu","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s004150050078","article-title":"Subcortical type cognitive impairment in herpes zoster encephalitis","volume":"244","author":"Hokkanen","year":"1997","journal-title":"J. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101045","DOI":"10.1016\/j.arr.2020.101045","article-title":"Prevention of dementia in an aging world: Evidence and biological rationale","volume":"64","author":"Grande","year":"2020","journal-title":"Aging Res. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Aging and Parkinson\u2019s disease: Why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Aging Res. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1111\/ene.15025","article-title":"Association between body weight variability and incidence of Parkinson disease: A nationwide, population-based cohort study","volume":"28","author":"Park","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ene.13844","article-title":"Levodopa\/carbidopa intestinal gel infusion and weight loss in Parkinson\u2019s disease","volume":"26","author":"Fabbri","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2007.10.004","article-title":"Frailty in Parkinson\u2019s disease and its clinical implications","volume":"14","author":"Ahmed","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"ref_57","first-page":"100095","article-title":"Frailty in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"4","author":"McMillan","year":"2021","journal-title":"Clin. Park. Relat. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Fan, S., Liang, X., Yun, T., Pei, Z., Hu, B., Ismail, Z., Yang, Z., and Xu, F. (2020). Mild behavioral impairment is related to frailty in non-dementia older adults: A cross-sectional study. BMC Geriatr., 20.","DOI":"10.1186\/s12877-020-01903-2"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jare.2017.09.004","article-title":"Impulse control disorder and response-inhibition alterations in Parkinson\u2019s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature","volume":"8","author":"Palermo","year":"2017","journal-title":"J. Adv. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fpsyg.2018.01765","article-title":"Role of the Cingulate Cortex in Dyskinesias-Reduced-Self-Awareness: An fMRI Study on Parkinson\u2019s Disease Patients","volume":"9","author":"Palermo","year":"2018","journal-title":"Front. Psychol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/17423953211043101","article-title":"\u201cIt\u2019s a double whammy\u201d: A qualitative study of illness uncertainty in individuals with Parkinson\u2019s disease in the context of COVID-19","volume":"18","author":"Simpson","year":"2022","journal-title":"Chronic Illn."},{"key":"ref_62","unstructured":"Simpson, J., Eccles, F., Murray, C., Garner, I., and Doyle, C. (2022). The Impact of COVID-19 Restrictions on People Affected by Parkinson\u2019s Findings from the Second Survey by Parkinson\u2019s UK and Comparison between Survey 1 and 2, Lancaster University."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"581144","DOI":"10.3389\/fpsyt.2020.581144","article-title":"COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson\u2019s Disease in the Elderly","volume":"11","author":"Janiri","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2020.08.012","article-title":"Predictors of COVID-19 outcome in Parkinson\u2019s disease","volume":"78","author":"Fasano","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.17219\/acem\/144135","article-title":"Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions","volume":"30","author":"Holland","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41531-021-00160-3","article-title":"How COVID-19 will boost remote exercise-based treatment in Parkinson\u2019s disease: A narrative review","volume":"7","author":"Langer","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3233\/JAD-210319","article-title":"Dementia and Parkinson\u2019s Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19","volume":"84","author":"Rutten","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1007\/s00415-020-10272-0","article-title":"COVID-19 in Parkinson\u2019s disease: What holds the key?","volume":"268","author":"Monreal","year":"2021","journal-title":"J. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","article-title":"Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2\/CARD15-defensin beta2 innate immune pathway defective in Crohn disease","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Clinical Management of Ebola Virus Disease in the United States and Europe","volume":"374","author":"Uyeki","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fphys.2014.00151","article-title":"Impact of vitamin D on immune function: Lessons learned from genome-wide analysis","volume":"5","author":"Chun","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virol.2019.10.011","article-title":"Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral replication","volume":"539","author":"Bai","year":"2020","journal-title":"Virology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijid.2020.12.077","article-title":"Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis","volume":"104","author":"Liu","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MCO.0000000000000700","article-title":"Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome","volume":"24","author":"Biesalski","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18433\/jpps32590","article-title":"Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis","volume":"25","author":"Hu","year":"2022","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1079\/PNS2003297","article-title":"Geographical differences in vitamin D status, with particular reference to European countries","volume":"62","author":"Ovesen","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1017\/S0007114521005080","article-title":"Influence of geographical latitude on vitamin D status: Cross-sectional results from the BiomarCaRE consortium","volume":"128","author":"Oskarsson","year":"2022","journal-title":"Br. J. Nutr."},{"key":"ref_78","first-page":"3086","article-title":"Vitamin D status and redefining serum parathyroid hormone reference range in the elderly","volume":"86","author":"Souberbielle","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00198-003-1390-7","article-title":"Prevalence of hypovitaminosis D in elderly women in Italy: Clinical consequences and risk factors","volume":"14","author":"Isaia","year":"2003","journal-title":"Osteoporos. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jamda.2019.09.021","article-title":"Vitamin D Supplementation for Extraskeletal Indications in Older Persons","volume":"21","author":"Bode","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1172\/JCI111373","article-title":"Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis","volume":"73","author":"Tsai","year":"1984","journal-title":"J. Clin. Investig."},{"key":"ref_82","first-page":"1","article-title":"Pinpointing a Role for Vitamin D in Frailty: A Time for Animal Models?","volume":"3","author":"Seldeen","year":"2021","journal-title":"Adv. Geriatr. Med. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2016.09.003","article-title":"Association of vitamin D deficiency and frailty: A systematic review and meta-analysis","volume":"94","author":"Zhou","year":"2016","journal-title":"Maturitas"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2015.03.014","article-title":"Sarcopenia in post-menopausal women: Is there any role for vitamin D?","volume":"82","author":"Anagnostis","year":"2015","journal-title":"Maturitas"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Marcos-P\u00e9rez, D., S\u00e1nchez-Flores, M., Proietti, S., Bonassi, S., Costa, S., Teixeira, J.P., Fern\u00e1ndez-Tajes, J., P\u00e1saro, E., Valdiglesias, V., and Laffon, B. (2020). Low Vitamin D Levels and Frailty Status in Older Adults: A Systematic Review and Meta-Analysis. Nutrients, 12.","DOI":"10.3390\/nu12082286"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00394-018-1634-0","article-title":"The association between 25-hydroxyvitamin D concentration, physical performance and frailty status in older adults","volume":"58","author":"Vaes","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"922673","DOI":"10.3389\/fnut.2022.922673","article-title":"The role of vitamin D in the link between physical frailty and cognitive function: A mediation analysis in community-dwelling Chinese older adults","volume":"9","author":"Xiong","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Pignolo, A., Mastrilli, S., Dav\u00ec, C., Arnao, V., Aridon, P., Dos Santos Mendes, F.A., Gagliardo, C., and D\u2019Amelio, M. (2022). Vitamin D and Parkinson\u2019s Disease. Nutrients, 14.","DOI":"10.3390\/nu14061220"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneurol.2011.30","article-title":"High prevalence of hypovitaminosis D status in patients with early Parkinson disease","volume":"68","author":"Evatt","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","article-title":"Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease","volume":"65","author":"Evatt","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_91","first-page":"547","article-title":"Memory, mood, and vitamin D in persons with Parkinson\u2019s disease","volume":"3","author":"Peterson","year":"2013","journal-title":"J. Park. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"993033","DOI":"10.3389\/fphar.2022.993033","article-title":"Understanding the role of \u201csunshine vitamin D\u201d in Parkinson\u2019s disease: A review","volume":"13","author":"Behl","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101441","DOI":"10.1016\/j.inat.2021.101441","article-title":"Vitamin D and its\u2019 role in Parkinson\u2019s disease patients with SARS-CoV-2 infection. A review article","volume":"27","author":"Azzam","year":"2022","journal-title":"Interdiscip. Neurosurg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"333.e1","DOI":"10.1016\/j.ajem.2021.02.050","article-title":"Part of the Covid19 puzzle: Acute parkinsonism","volume":"47","author":"Akilli","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12020-021-02749-3","article-title":"Vitamin D in the COVID-19 era: A review with recommendations from a G.I.O.S.E.G. expert panel","volume":"72","author":"Ulivieri","year":"2021","journal-title":"Endocrine"},{"key":"ref_96","first-page":"581","article-title":"Encepahlitis lethargica","volume":"30","year":"1917","journal-title":"Wien. Klin. Wochenschrift."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cavallieri, F., Fioravanti, V., Bove, F., Del Prete, E., Meoni, S., Grisanti, S., Zedde, M., Pascarella, R., Moro, E., and Valzania, F. (2022). COVID-19 and Parkinsonism: A Critical Appraisal. Biomolecules, 12.","DOI":"10.3390\/biom12070970"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_99","first-page":"455","article-title":"The \u03b1 -Synuclein Origin and Connectome Model (SOC Model) of Parkinson\u2019s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105626","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson\u2019s disease","volume":"164","author":"Horsager","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/PJNNS.a2020.0097","article-title":"Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)","volume":"55","author":"Alster","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5603\/PJNNS.a2022.0014","article-title":"Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns","volume":"56","author":"Madetko","year":"2022","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/bs.irn.2022.04.005","article-title":"COVID-19 and Parkinson\u2019s disease: Nursing care, vaccination and impact on advanced therapies","volume":"165","author":"Roszmann","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_105","first-page":"3","article-title":"COVID-19 Vaccination for Persons with Parkinson\u2019s Disease: Light at the End of the Tunnel?","volume":"11","author":"Bloem","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/jmv.26817","article-title":"Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study","volume":"93","author":"Cheng","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijmr.IJMR_2711_20","article-title":"SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia","volume":"153","author":"Munivenkatappa","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Palermo, S. (2019). Parkinson\u2019s Disease and Beyond\u2014A Neurocognitive Approach, IntechOpen Limited.","DOI":"10.5772\/intechopen.79277"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"786734","DOI":"10.3389\/fneur.2021.786734","article-title":"Resting State Functional Connectivity Signatures of MRgFUS Vim Thalamotomy in Parkinson\u2019s Disease: A Preliminary Study","volume":"12","author":"Stanziano","year":"2021","journal-title":"Front. Neurol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/4\/528\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:15Z","timestamp":1760122875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/4\/528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":109,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["brainsci13040528"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13040528","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}